SCHEMBL7413890

SCHEMBL7413890

c1ccc(-c2ccc(C(c3ccccc3)n3cncn3)cc2)cc1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 15/20 0.83
CYP26A1 O43174 2/20 0.69
CYP3A4 P08684 2/20 0.57
CYP11B1 P15538 1/20 0.57
TSHR P16473 1/20 0.57
CYP11B2 P19099 1/20 0.57
CYP2C19 P33261 1/20 0.57
CYP17A1 P05093 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
TDP1 Q9NUW8 2/20 0.53
NR1I2 O75469 1/20 0.53
USP2 O75604 1/20 0.53
ABCB11 O95342 1/20 0.53
ALDH1A1 P00352 1/20 0.53
PLA2G1B P04054 1/20 0.53
TP53 P04637 1/20 0.53
PGR P06401 1/20 0.53
HSP90AA1 P07900 1/20 0.53
MAPT P10636 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11367077 0.98 CYP19A1 (0.79) CYP19A1CYP26A1CYP3A4CYP11B1TSHR
SCHEMBL13292485 0.91 CYP19A1 (1.00) CYP19A1CYP26A1CYP3A4CYP11B1TSHR
SCHEMBL11355092 0.91 CYP19A1 (0.79) CYP19A1CYP26A1CYP3A4CYP11B1TSHR
SCHEMBL11362156 0.91 CYP19A1 (0.68) CYP19A1CYP26A1CYP3A4CYP11B1TSHR
SCHEMBL11355223 0.91 CYP19A1 (0.79) CYP19A1CYP26A1CYP3A4CYP11B1TSHR
SCHEMBL11354814 0.87 CYP19A1 (0.63) CYP19A1CYP26A1CYP3A4CYP11B1TSHR
SCHEMBL11362599 0.87 CYP19A1 (0.63) CYP19A1CYP26A1CYP3A4CYP11B1TSHR
SCHEMBL11353444 0.87 CYP19A1 (0.63) CYP19A1CYP26A1CYP3A4CYP11B1TSHR
SCHEMBL11361161 0.84 CYP19A1 (0.58) CYP19A1CYP26A1CYP3A4CYP11B1TSHR
SCHEMBL11365362 0.84 CYP19A1 (0.58) CYP19A1CYP26A1CYP3A4CYP11B1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527851-B1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS SEARLE & CO (US) 1998-12-23 EP disclosed
US-5674879-A Compositions including and methods of using conformationally restricted angiotensin II antagonist G.D. SEARLE & CO. (US) 1997-10-07 US disclosed
US-5602153-A Method of using 1-arylheteroarylalkyl substituted-1H-1,2,4-triazole compounds for treatment of a giaucoma disorder G.D. SEARLE & CO. (US) 1997-02-11 US disclosed
EP-0619819-B1 1-ARYLHETEROARYLALKYL SUBSTITUTED-1H-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS SEARLE & CO (US) 1996-06-12 EP disclosed
EP-0508445-B1 1-Arylheteroarylalkyl substituted-1H-1,2,4-triazole compounds for treatment of circulatory disorders SEARLE & CO (US) 1996-06-12 EP disclosed
US-5426105-A Cardiovascular disorders G.D. SEARLE & CO. (US) 1995-06-20 US disclosed
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
WO-1992018092-A2 1-ARYLHETEROARYLALKYL SUBSTITUTED-1H-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-10-29 WO disclosed
EP-0508445-A1 1-Arylheteroarylalkyl substituted-1H-1,2,4-triazole compounds for treatment of circulatory disorders G.D. Searle & Co. (US) 1992-10-14 EP disclosed
US-5155117-A Hypotensive agents G. D. SEARLE & CO. (US) 1992-10-13 US disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed
US-4243670-A MICROBORICIDES; FUNGICIDES; SPORICIDES; HYGIENE BAYER AKTIENGESELLSCHAFT (DE) 1981-01-06 US disclosed